131 related articles for article (PubMed ID: 33406263)
41. Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis.
He Y; Bouwstra R; Wiersma VR; de Jong M; Jan Lourens H; Fehrmann R; de Bruyn M; Ammatuna E; Huls G; van Meerten T; Bremer E
Nat Commun; 2019 Feb; 10(1):533. PubMed ID: 30710089
[TBL] [Abstract][Full Text] [Related]
42. GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation.
Ariake K; Ohtsuka H; Motoi F; Douchi D; Oikawa M; Rikiyama T; Fukase K; Katayose Y; Egawa S; Unno M
Cancer Lett; 2012 Dec; 325(1):99-107. PubMed ID: 22750095
[TBL] [Abstract][Full Text] [Related]
43. Polarity-regulating kinase partitioning-defective 1b (PAR1b) phosphorylates guanine nucleotide exchange factor H1 (GEF-H1) to regulate RhoA-dependent actin cytoskeletal reorganization.
Yamahashi Y; Saito Y; Murata-Kamiya N; Hatakeyama M
J Biol Chem; 2011 Dec; 286(52):44576-84. PubMed ID: 22072711
[TBL] [Abstract][Full Text] [Related]
44. ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide exchange activity toward RhoA.
Fujishiro SH; Tanimura S; Mure S; Kashimoto Y; Watanabe K; Kohno M
Biochem Biophys Res Commun; 2008 Mar; 368(1):162-7. PubMed ID: 18211802
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-200a Promotes Phagocytosis of Macrophages and Suppresses Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma by Targeting CD47.
Zhao Y; Yu X; Tang H; Han R; Wang X; Wang J; Wang K; Li G
Biomed Res Int; 2020; 2020():3723781. PubMed ID: 32149101
[TBL] [Abstract][Full Text] [Related]
46. The role of Mg2+ cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins.
Zhang B; Zhang Y; Wang Z; Zheng Y
J Biol Chem; 2000 Aug; 275(33):25299-307. PubMed ID: 10843989
[TBL] [Abstract][Full Text] [Related]
47. HIV-1 Vpu Promotes Phagocytosis of Infected CD4
Cong L; Sugden SM; Leclair P; Lim CJ; Pham TNQ; Cohen ÉA
mBio; 2021 Aug; 12(4):e0192021. PubMed ID: 34425695
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
[TBL] [Abstract][Full Text] [Related]
49. Phosphoinositide 3-kinase C2β regulates RhoA and the actin cytoskeleton through an interaction with Dbl.
Błajecka K; Marinov M; Leitner L; Uth K; Posern G; Arcaro A
PLoS One; 2012; 7(9):e44945. PubMed ID: 22984590
[TBL] [Abstract][Full Text] [Related]
50. A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy.
del Vescovo CD; Cotecchia S; Diviani D
Mol Cell Biol; 2013 Jan; 33(1):14-27. PubMed ID: 23090968
[TBL] [Abstract][Full Text] [Related]
51. The microtubule-associated Rho activating factor GEF-H1 interacts with exocyst complex to regulate vesicle traffic.
Pathak R; Delorme-Walker VD; Howell MC; Anselmo AN; White MA; Bokoch GM; Dermardirossian C
Dev Cell; 2012 Aug; 23(2):397-411. PubMed ID: 22898781
[TBL] [Abstract][Full Text] [Related]
52. An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity.
Wang X; Wang Y; Hu J; Xu H
Cancer Med; 2021 Mar; 10(6):2125-2136. PubMed ID: 33629544
[TBL] [Abstract][Full Text] [Related]
53. Role of Lbc RhoGEF in Galpha12/13-induced signals to Rho GTPase.
Dutt P; Nguyen N; Toksoz D
Cell Signal; 2004 Feb; 16(2):201-9. PubMed ID: 14636890
[TBL] [Abstract][Full Text] [Related]
54. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
55. CD47 promotes neuronal development through Src- and FRG/Vav2-mediated activation of Rac and Cdc42.
Murata T; Ohnishi H; Okazawa H; Murata Y; Kusakari S; Hayashi Y; Miyashita M; Itoh H; Oldenborg PA; Furuya N; Matozaki T
J Neurosci; 2006 Nov; 26(48):12397-407. PubMed ID: 17135401
[TBL] [Abstract][Full Text] [Related]
56. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
Eitaki M; Yamamori T; Meike S; Yasui H; Inanami O
BMC Cancer; 2012 Oct; 12():469. PubMed ID: 23057787
[TBL] [Abstract][Full Text] [Related]
57. Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPα Interaction as a Potential Cancer Immunotherapy.
Hazama D; Yin Y; Murata Y; Matsuda M; Okamoto T; Tanaka D; Terasaka N; Zhao J; Sakamoto M; Kakuchi Y; Saito Y; Kotani T; Nishimura Y; Nakagawa A; Suga H; Matozaki T
Cell Chem Biol; 2020 Sep; 27(9):1181-1191.e7. PubMed ID: 32640189
[TBL] [Abstract][Full Text] [Related]
58. Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis.
Yang H; Shao R; Huang H; Wang X; Rong Z; Lin Y
Cancer Med; 2019 Aug; 8(9):4245-4253. PubMed ID: 31183992
[TBL] [Abstract][Full Text] [Related]
59. The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration.
Tsapara A; Luthert P; Greenwood J; Hill CS; Matter K; Balda MS
Mol Biol Cell; 2010 Mar; 21(6):860-70. PubMed ID: 20089843
[TBL] [Abstract][Full Text] [Related]
60. Redox regulation of ephrin/integrin cross-talk.
Buricchi F; Giannoni E; Grimaldi G; Parri M; Raugei G; Ramponi G; Chiarugi P
Cell Adh Migr; 2007; 1(1):33-42. PubMed ID: 19262085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
